Who is sponsoring NCT05094193?

NCT05094193 is sponsored by Tunis University.

What drugs are being tested in NCT05094193?

Interventions in NCT05094193: Trocar-site infiltration, TAP block, Trocar site infiltration placebo, TAP block placebo.

What condition does NCT05094193 study?

NCT05094193 studies Laparoscopic Cholecystectomy.

Is NCT05094193 still recruiting?

NCT05094193 is currently status unknown. Last updated 26 October 2021.

Last reviewed 2021-10-26 · How we verify

NCT05094193

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Trocar-site Infiltration Versus TAP-block

Status unknown NA Last updated 26 October 2021

What this trial tests

NA trial testing Trocar-site infiltration in Laparoscopic Cholecystectomy in 100 participants. Status unknown.

Timeline

1 October 2021

Primary endpoint
31 December 2021

31 January 2022

Quick facts

Lead sponsor	Tunis University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	triple
Primary purpose	treatment
Enrollment	100
Start date	1 October 2021
Primary completion	31 December 2021
Estimated completion	31 January 2022
Sites	1 location across Tunisia

Drugs / interventions tested

Trocar-site infiltration
TAP block
Trocar site infiltration placebo
TAP block placebo

Conditions studied

Laparoscopic Cholecystectomy — all drugs for Laparoscopic Cholecystectomy →

Sponsor

Tunis University

Who can join

Adults 18 to 65, any sex, with Laparoscopic Cholecystectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

For symptomatic gall bladder disorders (cholelithiasis and cholecystitis), laparoscopic cholecystectomy (LC) has been considered as the gold standard treatment. However, these minimally invasive technique is associated with acute moderate pain during the 24 hours postoperative, which is routinely managed using opioids. The transversus abdominis plane (TAP) block has been used as part of a multimodal analgesia strategy. Besides, Wang et al found that TAP block is more effective than a conventional pain control, but not significatively different from another local incisional pain control that is port site infiltration.So, the aim of this study, is to compare the analgesic efficacy and safety of trocar-site infiltration with ropivacaine with ultrasound-guided TAP block following laparoscopic cholecystectomy when used as part of multimodal analgesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Laparoscopic Cholecystectomy

Currently open trials in the same condition.

NCT07440940 — Timing of Subcostal TAPB Combined With Rectus Sheath Block for Postoperative Pain After Laparoscopic Cholecystectomy · NA · recruiting
NCT07488078 — Effect of Liberal and Restrictive IV Fluids on Recovery After Gallbladder Surgery · Phase 1 · recruiting
NCT06632184 — Peritoneal Lavage Using Saline or Saline With Ondansetron for Pain Control After Laparoscopic Cholecystectomy · Phase 4 · active not recruiting
NCT07445854 — Sensory Analysis and Cutaneous Mapping of Different Regional Anesthesia Techniques · recruiting
NCT07186803 — AI and Safety in Laparoscopic Cholecystectomy: A Randomized Controlled Trial · Phase 3 · recruiting

Other Tunis University trials

Trials by the same sponsor.

NCT06655571 — What Technique for Caudal Block in Children: Conventional or Ultrasound-guided · NA · recruiting
NCT06670846 — Management of Preoperative Anxiety in Children: Could a Lollipop Be the Solution? · NA · recruiting
NCT06655168 — Orotracheal Intubation in Newborns: Videolaryngoscopy Vs Direct Laryngoscopy · NA · recruiting
NCT07459088 — Central Venous Catheterization in Children: Jugulo-subclavian Venous Confluence Versus Internal Jugular Vein · NA · completed
NCT07088432 — Intravenous Dexamethasone for Prolonging Sensory Block in Spinal Anesthesia · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05094193 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tunis University
Last refreshed: 26 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05094193.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing